Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Laboratory Corporation of America Holdings    LH

LABORATORY CORPORATION OF AMERICA HOLDIN

(LH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/14/2020 02/18/2020 02/19/2020 02/20/2020 02/21/2020 Date
195.28(c) 190.94(c) 189.9(c) 188.81(c) 189.56(c) Last
649 497 791 626 564 484 641 419 436 814 Volume
+0.28% -2.22% -0.54% -0.57% +0.40% Change
More quotes
Financials (USD)
Sales 2020 12 090 M
EBIT 2020 1 781 M
Net income 2020 948 M
Debt 2020 5 464 M
Yield 2020 -
Sales 2021 12 506 M
EBIT 2021 1 852 M
Net income 2021 1 039 M
Debt 2021 4 726 M
Yield 2021 -
P/E ratio 2020 19,6x
P/E ratio 2021 17,8x
EV / Sales2020 1,98x
EV / Sales2021 1,85x
Capitalization 18 425 M
More Financials
Company
Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows: - supply of testing services (62%): routine testing, patient diagnosis, disease monitoring and treatment, and other services; -... 
More about the company
Surperformance© ratings of Laboratory Corporation of
Trading Rating : Investor Rating :
More Ratings
Latest news on LABORATORY CORPORATION OF
02/13LABCORP : 4Q Earnings Snapshot
AQ
02/13LABORATORY CORP OF AMERICA HOLDINGS : Financial Statements and Exhibits (form 8-..
AQ
02/13LABCORP : Announces 2019 Fourth Quarter and Full Year Results and Provides 2020 ..
BU
02/10LABORATORY CORPORATION OF AMERICA HO : annual earnings release
02/06LABORATORY CORP OF AMERICA HOLDINGS : Amendments to Articles of Inc. or Bylaws; ..
AQ
01/22LABORATORY OF AMERICA : LabCorp Earns 100 Percent on Human Rights Campaign Found..
AQ
01/21LABCORP : Earns 100 Percent on Human Rights Campaign Foundation's Annual Scoreca..
BU
01/15LABORATORY OF AMERICA : LabCorp to Adopt Thermo Fisher Scientific's Ion Torrent ..
AQ
01/14LABORATORY OF AMERICA : LabCorp to Adopt Thermo Fisher Scientific's Ion Torrent ..
BU
01/14LABORATORY CORP OF AMERICA HOLDINGS : Regulation FD Disclosure (form 8-K)
AQ
01/13LABCORP : to Announce Fourth Quarter and Full Year 2019 Financial Results on Feb..
BU
01/13LABCORP : and Covance Launch Extensive Preclinical, Clinical and Post-Approval C..
BU
01/10LABORATORY OF AMERICA : Cautionary Statement Regarding Forward-Looking Statement..
PU
01/06LABORATORY CORP OF AMERICA HOLDINGS : Financial Statements and Exhibits (form 8-..
AQ
01/06LABCORP : is Scheduled to Present at the 38th Annual J.P. Morgan Healthcare Conf..
BU
More news
News in other languages on LABORATORY CORPORATION OF
02/10LABORATORY CORPORATION OF AMERICA HO : Veröffentlichung des Jahresergebnisses
02/10LABORATORY CORPORATION OF AMERICA HO : publication des résultats annuels
2019STOCK MARKET PARIS : Les valeurs à suivre à Paris et en Europe (actualisé)
2018LABORATORY OF AMERICA : Covance und Definiens arbeiten zusammen an Integration d..
2018LABORATORY OF AMERICA : LabCorp et Unilabs collaborent en vue d'étendre la porté..
More news
Analyst Recommendations on LABORATORY CORPORATION OF
More recommendations
Sector news : Healthcare Facilities & Services - NEC
02/20Fresenius forecasts 2020 profit growth driven by drug, dialysis units
RE
02/20Fresenius 4Q Net Profit Flat; Creates JV With Vifor in China
DJ
02/19FRESENIUS MEDICAL CARE : says fourth-quarter operating profit up 3%
RE
02/19FRESENIUS : Subsidiary to Acquire Hospital in Bogota
DJ
02/14Canada Seeks Talks to End Rail Blockades -- Update
DJ
More sector news : Healthcare Facilities & Services - NEC
Chart LABORATORY CORPORATION OF AMERICA HOLDINGS
Duration : Period :
Laboratory Corporation of America Holdings Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LABORATORY CORPORATION OF
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 205,56  $
Last Close Price 189,56  $
Spread / Highest target 18,7%
Spread / Average Target 8,44%
Spread / Lowest Target -8,21%
EPS Revisions
Managers
NameTitle
Adam H. Schechter President, Chief Executive Officer & Director
David P. King Chairman
Glenn Andrew Eisenberg Chief Financial Officer, Treasurer & Executive VP
Lance V. Berberian Chief Information Officer & Senior Vice President
Stephen M. Anderson Chief Scientific Officer-Covance & Senior VP